Skip to Content

Immunotherapy of Sepsis Using anti-PDL1 antibody

PIs: Sachin Yende, MD; Derek Angus, MD

NIH/NIGMS R34GM107650 (Project period: 7/1/15 to 6/30/17)

Severe sepsis is a major health problem and few therapies have improved outcomes of these patients. We will use a novel approach to test a new treatment that has improved outcomes in patients with cancer. If successful, this treatment will hasten recovery and save thousands of lives each year.